The article below is just the first page of a 5-page article, and the hyperlink below will bring up the entire article 2011.12 InterRights Bulletin Article_only
Filed under: General Problems | 3 Comments »
Journavx: not suitable for chronic pain or the most severe acute pain cases
Posted on May 28, 2025 by Pharmaciststeve
Overview of Vertex’s New Acute Pain Medication: Journavx (Suzetrigine) Vertex Pharmaceuticals’ Journavx (suzetrigine) is a newly FDA-approved, first-in-class, non-opioid oral medication for moderate-to-severe acute pain, such as that experienced after surgery or injury1231014. It represents the first new class of acute pain therapy in over 20 years and has generated significant interest among clinicians and […]
Filed under: General Problems | 2 Comments »